AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2024 Issue 4; ICD-10-PCS New/Revised Codes Section X – New Technology

Marnetegragene Autotemcel

In table XW1, Transfusion of Anatomical Regions, substance value 7 Marnetegragene Autotemcel was added to the body part values 3 Peripheral Vein and 4 Central Vein.Body Part Approach Device/Substance/Technology Qualifier 3 Peripheral Vein 4 Central Vein 3 Percutaneous 7 Marnetegragene Autotemcel A New Technology Group 10 Marnetegragene autotemcel (RP-L201) is an autologous gene therapy that uses the patient’s hematopoietic stem cells to treat severe leukocyte adhesion deficiency Type 1 (LAD-1). LAD-1 is an extremely rare genetic condition that causes the loss of immune response that results in recurrent infections. ...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.